[HTML][HTML] Photodynamic therapy for esophageal cancer
T Yano, K Hatogai, H Morimoto, Y Yoda… - Annals of Translational …, 2014 - ncbi.nlm.nih.gov
Photodynamic therapy (PDT) is a treatment that uses a photosensitizing drug that is
administered to the patient, localized to a tumor, and then activated with a laser to induce a …
administered to the patient, localized to a tumor, and then activated with a laser to induce a …
Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma: data from the open-label, phase II KEYNOTE-224 trial
G Verset, I Borbath, M Karwal, C Verslype… - Clinical cancer …, 2022 - AACR
Abstract Purpose: KEYNOTE-224 cohort 1 demonstrated that pembrolizumab was
efficacious and tolerable in patients with advanced hepatocellular carcinoma (HCC) …
efficacious and tolerable in patients with advanced hepatocellular carcinoma (HCC) …
[HTML][HTML] Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
K Hatogai, S Kitano, S Fujii, T Kojima, H Daiko… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Immunotherapy with anti-PD-1 antibody preliminarily showed promising efficacy for treating
esophageal squamous cell carcinoma (ESCC). Herein, we used tissue microarrays and …
esophageal squamous cell carcinoma (ESCC). Herein, we used tissue microarrays and …
Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery
K Hatogai, S Fujii, T Kojima, H Daiko… - Journal of Surgical …, 2016 - Wiley Online Library
Background and objectives To clarify prognostic factors for the patients with esophageal
squamous cell carcinoma (ESCC) through an assessment of surgically resected specimens …
squamous cell carcinoma (ESCC) through an assessment of surgically resected specimens …
[HTML][HTML] Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
C Labbate, K Hatogai, R Werntz, WM Stadler… - … for immunotherapy of …, 2019 - Springer
Background Clinically localized renal cell carcinoma is treated primarily with surgery
followed by observation or adjuvant sunitinib in selected high-risk patients. The checkpoint …
followed by observation or adjuvant sunitinib in selected high-risk patients. The checkpoint …
[HTML][HTML] Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
AT cell-inflamed tumor microenvironment is characterized by the accumulation and local
activation of CD8+ T cells and Bat3-lineage dendritic cells, which together are associated …
activation of CD8+ T cells and Bat3-lineage dendritic cells, which together are associated …
Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma
K Hatogai, T Yano, T Kojima, M Onozawa… - Gastrointestinal …, 2016 - Elsevier
Background and Aims Photodynamic therapy (PDT) is a less-invasive salvage treatment
option for local failure at the primary site after chemoradiotherapy (CRT) for esophageal …
option for local failure at the primary site after chemoradiotherapy (CRT) for esophageal …
[HTML][HTML] Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell …
K Hatogai, S Fujii, S Kitano, T Kojima, H Daiko… - British Journal of …, 2020 - nature.com
Background Tumour microenvironments can differ according to intratumoural locations. We
investigated the immune status at different locations in primary tumours and its clinical …
investigated the immune status at different locations in primary tumours and its clinical …
The tumor microenvironment of bladder cancer
K Hatogai, RF Sweis - Tumor Microenvironments in Organs: From the …, 2020 - Springer
Bladder cancer has been well known as immunotherapy-responsive disease as intravesical
therapy with BCG has been the standard of care for non-muscle invasive disease for several …
therapy with BCG has been the standard of care for non-muscle invasive disease for several …
[HTML][HTML] Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer
K Hatogai, T Yano, T Kojima, M Onozawa, S Fujii… - Radiation …, 2016 - Springer
Background Salvage endoscopic therapy (SET), such as endoscopic mucosal resection
(EMR) and photodynamic therapy (PDT), is a less-invasive treatment for local failure at the …
(EMR) and photodynamic therapy (PDT), is a less-invasive treatment for local failure at the …